These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7841859)

  • 21. Sustained withdrawal allows normalization of in vivo [11C]N-methylspiperone dopamine D2 receptor binding after chronic binge cocaine: a positron emission tomography study in rats.
    Maggos CE; Tsukada H; Kakiuchi T; Nishiyama S; Myers JE; Kreuter J; Schlussman SD; Unterwald EM; Ho A; Kreek MJ
    Neuropsychopharmacology; 1998 Aug; 19(2):146-53. PubMed ID: 9629568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Motoric signs of CNS dysfunction associated with alcohol and cocaine withdrawal.
    Bauer LO
    Psychiatry Res; 1993 Apr; 47(1):69-77. PubMed ID: 8516418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioral response to buspirone in cocaine and phencyclidine withdrawal.
    Giannini AJ; Loiselle RH; Graham BH; Folts DJ
    J Subst Abuse Treat; 1993; 10(6):523-7. PubMed ID: 8308936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study.
    Satel SL; Price LH; Palumbo JM; McDougle CJ; Krystal JH; Gawin F; Charney DS; Heninger GR; Kleber HD
    Am J Psychiatry; 1991 Dec; 148(12):1712-6. PubMed ID: 1957935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased activity of rat A10 dopamine neurons following withdrawal from repeated cocaine.
    Ackerman JM; White FJ
    Eur J Pharmacol; 1992 Jul; 218(1):171-3. PubMed ID: 1397028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical ratings and plasma HVA during cocaine abstinence.
    Martin SD; Yeragani VK; Lodhi R; Galloway MP
    Biol Psychiatry; 1989 Aug; 26(4):356-62. PubMed ID: 2765598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adverse effects of stimulant drugs in a community sample of drug users.
    Williamson S; Gossop M; Powis B; Griffiths P; Fountain J; Strang J
    Drug Alcohol Depend; 1997 Mar; 44(2-3):87-94. PubMed ID: 9088780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic neuropharmacology of cocaine: progress in pharmacotherapy.
    Gawin FH
    J Clin Psychiatry; 1988 Feb; 49 Suppl():11-6. PubMed ID: 3276669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The physiology of cocaine craving and 'crashing'.
    Dackis CA; Gold MS; Sweeney DR
    Arch Gen Psychiatry; 1987 Mar; 44(3):298-300. PubMed ID: 3827524
    [No Abstract]   [Full Text] [Related]  

  • 30. Bromocriptine in cocaine withdrawal--does it work?
    Teller DW; Devenyi P
    Int J Addict; 1988 Nov; 23(11):1197-205. PubMed ID: 3069753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Withdrawal and dependency symptoms among adolescent alcohol and drug abusers.
    Stewart DG; Brown SA
    Addiction; 1995 May; 90(5):627-35. PubMed ID: 7795499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence.
    Acquas E; Di Chiara G
    J Neurochem; 1992 May; 58(5):1620-5. PubMed ID: 1313849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Daily cocaine craving in a 3-week inpatient treatment program.
    Flowers Q; Elder IR; Voris J; Sebastian PS; Blevins O; Dubois J
    J Clin Psychol; 1993 Mar; 49(2):292-7. PubMed ID: 8387547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selegiline prevents long-term changes in dopamine efflux and stress immobility during the second and third weeks of abstinence following opiate withdrawal.
    Grasing K; Ghosh S
    Neuropharmacology; 1998 Aug; 37(8):1007-17. PubMed ID: 9833630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Matrix model of outpatient stimulant abuse treatment: evidence of efficacy.
    Shoptaw S; Rawson RA; McCann MJ; Obert JL
    J Addict Dis; 1994; 13(4):129-41. PubMed ID: 7734464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered levels of sex and stress steroid hormones assessed daily over a 28-day cycle in early abstinent cocaine-dependent females.
    Fox HC; Hong KA; Paliwal P; Morgan PT; Sinha R
    Psychopharmacology (Berl); 2008 Jan; 195(4):527-36. PubMed ID: 17891383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of cocaine- and methamphetamine-evoked dopamine and glutamate overflow in somatodendritic and terminal field regions of the rat brain during acute, chronic, and early withdrawal conditions.
    Zhang Y; Loonam TM; Noailles PA; Angulo JA
    Ann N Y Acad Sci; 2001 Jun; 937():93-120. PubMed ID: 11458542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addiction-related alterations in D1 and D2 dopamine receptor behavioral responses following chronic cocaine self-administration.
    Edwards S; Whisler KN; Fuller DC; Orsulak PJ; Self DW
    Neuropsychopharmacology; 2007 Feb; 32(2):354-66. PubMed ID: 16541082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Event-related potential changes in cocaine withdrawal: evidence for long-term cognitive effects.
    Noldy NE; Carlen PL
    Neuropsychobiology; 1997; 36(1):53-6. PubMed ID: 9211446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cue-evoked arousal in cocaine users: a study of variance and predictive value.
    Negrete JC; Emil S
    Drug Alcohol Depend; 1992 Jun; 30(2):187-92. PubMed ID: 1321711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.